According to the issued ratings of 9 analysts in the last year, the consensus rating for Repligen stock is Moderate Buy based on the current 1 hold rating and 8 buy ratings for RGEN. The average twelve-month price prediction for Repligen is $199.00 with a high price target of $240.00 and a low price target of $165.00.Investors. These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments. RGEN currently has a PEG ratio of 8.90. Another notable valuation metric for REGN is its P/B ratio of 3.87. The P/B ratio pits a stock's market value against its book value, which is defined as ...Investors. These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments.RGEN currently has a PEG ratio of 8.90. Another notable valuation metric for REGN is its P/B ratio of 3.87. The P/B ratio pits a stock's market value against its book value, which is defined as ...Find the latest Regeneron Pharmaceuticals, Inc. (REGN) stock quote, history, news and other vital information to help you with your stock trading and investing.Repligen Corp. historical stock charts and prices, analyst ratings, financials, and today’s real-time RGEN stock price. See Repligen Corporation (RGEN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Investors. These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments.The Price and Consensus chart displays the company's stock price along with the consensus estimate. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The ...A month has gone by since the last earnings report for Repligen (RGEN Quick Quote RGEN - Free Report) . Shares have added about 2.9% in that time frame, outperforming the S&P 500. Will the recent ...Created with Sketch. when trading, helping you to optimize your price and have a successful order execution. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4 ...Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, RGEN has a P/B of 5.25.Sep 12, 2023 · Sentiment. Repligen oration (RGEN) has an AI Score of { {ai_score}}/10 (Buy) because its overall probability of beating the market (S&P 500) in the next 3 months (45.41%) is +44.41% vs. the average probability ( { {universal_probability}}%) of US stocks analyzed by our Artificial Intelligence. The AI-powered overall analysis of Repligen oration ... Analysts Offer Insights on Healthcare Companies: Repligen (RGEN), Penumbra (PEN) and Healthequity (HQY) September 6, 2023TipRanks. Repligen Corporation to Present at Wells Fargo Healthcare ...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Repligen (NASDAQ:RGEN) is scheduled to announce Q2 earnings results on Wednesday, August 2nd, before market open.The consensus EPS Estimate is $0.48 (-47.3% Y/Y) and the consensus Revenue Estimate ...Jul 22, 2022 · Repligen (RGEN) shares soared 15.3% in the last trading session to close at $203.64. The move was backed by solid volume with far more shares changing hands than in a normal session. RGEN Earnings Date and Information. Repligen last announced its earnings data on August 2nd, 2023. The biotechnology company reported $0.53 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.49 by $0.04. The company had revenue of $159.20 million for the quarter, compared to analyst estimates of $165.93 million.Sep 8, 2023 · During the last trading day the stock fluctuated 2.38% from a day low at $175.11 to a day high of $179.27. The price has risen in 9 of the last 10 days and is up by 11.37% over the past 2 weeks. Volume fell on the last day by -215 thousand shares and in total, 398 thousand shares were bought and sold for approximately $69.99 million. Repligen Corporation Common Stock (RGEN) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.86.18 -0.69(-0.79%) Gold 1,948.40 +5.90(+0.30%) PROGRAMMING ALERT: NEXT, a new series by Yahoo Finance, debuts Friday, September 8, at 10 a.m. ET Repligen Corporation (RGEN) NasdaqGS - NasdaqGS...During the last trading day the stock fluctuated 2.38% from a day low at $175.11 to a day high of $179.27. The price has risen in 9 of the last 10 days and is up by 11.37% over the past 2 weeks. Volume fell on the last day by -215 thousand shares and in total, 398 thousand shares were bought and sold for approximately $69.99 million.head soccer 2022
Repligen (RGEN) (Real Time Quote from BATS) $161.01 USD -7.19 (-4.28%) Updated Sep 8, 2023 03:04 PM ET Add to portfolio Zacks Rank: 5-Strong Sell 5 Style Scores: F Value | C Growth | C Momentum |...Should Weakness in Repligen Corporation's (NASDAQ:RGEN) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? (Simply Wall St.) Apr-26-23 08:00PM. RGEN: Lowering target price to $156.00. Repligen Corp. historical stock charts and prices, analyst ratings, financials, and today’s real-time RGEN stock price. Sep 13, 2022 · Discover historical prices for RGEN stock on Yahoo Finance. View daily, weekly or monthly format back to when Repligen Corporation stock was issued. Jun 2, 2022 · Weapons sent to Ukraine after Russia’s invasion in February will end up in the global hidden economy and in the hands of criminals, the head of Interpol has said. Jürgen Stock says once the ... Sep 11, 2023 · The Price and 12 Month EPS chart displays the company's stock price along with the trailing twelve month (TTM) EPS. A company's earnings per share, or EPS, is a key financial metric on its income ... Stock split history for Repligen since 1990. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values. Repligen Corporation is a leading provider of advanced bioprocessing technologies and solutions used by large biopharmaceutical companies ... Created with Sketch. when trading, helping you to optimize your price and have a successful order execution. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4 ...Repligen Corp’s ( RGEN) price is currently down 6.4% so far this month. During the month of February, Repligen Corp’s stock price has reached a high of $200.98 and a low of $164.04. Over the last year, Repligen Corp has hit prices as high as $262.26 and as low as $137.21. Year to date, Repligen Corp’s stock is down 34.51%.What is the target price for Repligen (RGEN) stock? A. The latest price target for Repligen ( NASDAQ: RGEN) was reported by Craig-Hallum on Thursday, August 3, 2023. The analyst firm set a price ...primepoint login
Find the latest Repligen Corporation (RGEN) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Investors. These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments.At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.www .repligen .com. Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs. 2014 The company is based in Waltham, Massachusetts, 2014 and incorporated in Delaware in 1981. [1] A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. [2]What Is Repligen Worth? The stock seems fairly valued at the moment according to my valuation model. It’s trading around 0.63% above my intrinsic value, which means if you buy Repligen today ...Sep 8, 2023 · Analyst Forecast. According to 9 analysts, the average rating for RGEN stock is "Strong Buy." The 12-month stock price forecast is $204.0, which is an increase of 26.38% from the latest price. What Is Repligen Worth? The stock seems fairly valued at the moment according to my valuation model. It’s trading around 0.63% above my intrinsic value, which means if you buy Repligen today ...See Repligen Corporation (RGEN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Key Data for RGEN Dividend. Annual Dividend / Yield. Annualized. Dividend Growth. (5 Year) Number of Dividend. Increases in the. Last Five Years. Payout Ratio.The average Repligen stock price prediction forecasts a potential upside of 23.42% from the current RGEN share price of $168.99. What is RGEN's forecast return on assets (ROA) for 2023-2025? (NASDAQ: RGEN) forecast ROA is 10.61%, which is lower than the forecast US Medical Instruments & Supplies industry average of 11.13%.Jan 13, 2022 · 5. Repligen. Finally, add Repligen ( RGEN 1.05%) to your list of the market's fastest-growing large-cap stocks. Repligen is a healthcare company, although it's not one most investors (or even ... Key Data for RGEN Dividend. Annual Dividend / Yield. Annualized. Dividend Growth. (5 Year) Number of Dividend. Increases in the. Last Five Years. Payout Ratio.ban ban
Shares of RGEN stock broke out of a cup base with a buy point at 212.65 on Thursday, according to MarketSmith.com. On the stock market today, RGEN stock gained 1.5% to close at 215.47. How much is Repligen stock worth today? ( NASDAQ: RGEN) Repligen currently has 55,756,322 outstanding shares. With Repligen stock trading at $162.92 per share, the total value of Repligen stock (market capitalization) is $9.08B. Repligen stock was originally listed at a price of $0.78 in Dec 31, 1997.Real time Repligen (RGEN) stock price quote, stock graph, news & analysis. Overview Stock Screener Earnings Calendar Sectors Nasdaq | RGEN U.S.: Nasdaq Repligen Corp. Watch list After Hours Last Updated: Sep 1, 2023 4:49 p.m. EDT Delayed quote $ 175.74 0.00 0.00%...RGEN Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Healthcare Equipment & Supplies. REPLIGEN CORPORATION. REPLIGEN CORPORATION 167.54 ‎-2.74%. 167.54. at closeRepligen Corp Follow Share $167.76 After Hours: $167.76 (0.00%) 0.00 Closed: Sep 6, 4:14:55 PM GMT-4 · USD · NASDAQ · Disclaimer search Compare to Novavax Inc $9.74RGEN will take a dip in the coming day RGEN is going to dip if you feel you’re going to take a loss on this stock I would advise selling sooner rather then later. The chart that I’ve referenced is the Vortex Indicator and from my analysis the lines are going to cross negatively.Repligen Corp. analyst estimates, including RGEN earnings per share estimates and analyst recommendations. Repligen Corp (NASDAQ:RGEN) 174.07 Delayed Data As of Aug 31 +1.35 / +0.78% Today’s Change 134.64 Today ||| 52-Week Range 235.06 +2.81% Year-to-Date Quote Profile News Charts Forecasts...Analyst Forecast. According to 9 analysts, the average rating for RGEN stock is "Strong Buy." The 12-month stock price forecast is $204.0, which is an increase of 26.38% from the latest price.marketbeat.com - August 20 at 4:36 AM. North Star Asset Management Inc. Has $14.98 Million Stock Holdings in Repligen Co. (NASDAQ:RGEN) marketbeat.com - August 18 at 2:22 PM. Sartorius and Repligen Corporation Launch Integrated System with Biostat STR® and XCell® ATF for Upstream Process Intensification.The average Repligen stock price prediction forecasts a potential upside of 23.42% from the current RGEN share price of $168.99. What is RGEN's forecast return on assets (ROA) for 2023-2025? (NASDAQ: RGEN) forecast ROA is 10.61%, which is lower than the forecast US Medical Instruments & Supplies industry average of 11.13%.RGEN stock reached its all-time high of around $327 just after the announcement, but profit-booking at higher levels resulted in RGEN stock falling to levels of $259 currently. Note that despite ...Created with Sketch. when trading, helping you to optimize your price and have a successful order execution. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4 ... Repligen Corp Follow Share $167.76 After Hours: $167.76 (0.00%) 0.00 Closed: Sep 6, 4:14:55 PM GMT-4 · USD · NASDAQ · Disclaimer search Compare to Novavax Inc $9.74 The Price and Consensus chart displays the company's stock price along with the consensus estimate. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The ... Shares of bioprocessing technology company Repligen ( RGEN -4.03%) were down by 10% on heavy volume as of 12:42 p.m. ET Tuesday. That steep decline appears to be connected to the first-quarter ...REGN Stock 12 Months Forecast. $895.94. (7.92% Upside) Based on 16 Wall Street analysts offering 12 month price targets for Regeneron in the last 3 months. The average price target is $895.94 with a high forecast of $1,050.00 and a low forecast of $665.00. The average price target represents a 7.92% change from the last price of $830.19.drawaria
Oct 12, 2021. The stock price of Repligen (NASDAQ: RGEN), a U.S.-based life sciences company involved in production of materials used in the manufacture of biological drugs, has seen a 12% drop ...Find the latest AdvanSix Inc. (ASIX) stock quote, history, news and other vital information to help you with your stock trading and investing.Repligen (NASDAQ:RGEN) is scheduled to announce Q2 earnings results on Wednesday, August 2nd, before market open.The consensus EPS Estimate is $0.48 (-47.3% Y/Y) and the consensus Revenue Estimate ...RGEN Earnings Date and Information. Repligen last announced its earnings data on August 2nd, 2023. The biotechnology company reported $0.53 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.49 by $0.04. The company had revenue of $159.20 million for the quarter, compared to analyst estimates of $165.93 million. RGEN will take a dip in the coming day RGEN is going to dip if you feel you’re going to take a loss on this stock I would advise selling sooner rather then later. The chart that I’ve referenced is the Vortex Indicator and from my analysis the lines are going to cross negatively.Feb 20, 2023 · What Is Repligen Worth? The stock seems fairly valued at the moment according to my valuation model. It’s trading around 0.63% above my intrinsic value, which means if you buy Repligen today ... Repligen (NASDAQ:RGEN) is scheduled to announce Q2 earnings results on Wednesday, August 2nd, before market open.The consensus EPS Estimate is $0.48 (-47.3% Y/Y) and the consensus Revenue Estimate ...Jun 24, 2023 · RGEN stock returns are also predicted based on historical data. According to our research, RGEN stock is a very good long-term investment. RGEN share price has been in a bull cycle for the past year. Repligen Corp ( RGEN) receives a weak valuation ranking of 32 from InvestorsObserver data analysis. The proprietary ranking system focuses on the underlying health of a company through analysis of its stock price, earnings, and growth rate. RGEN has a better value than 32% of stocks based on these valuation analytics.Jul 22, 2022 · Repligen (RGEN) shares soared 15.3% in the last trading session to close at $203.64. The move was backed by solid volume with far more shares changing hands than in a normal session. A high-level overview of Repligen Corporation (RGEN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Sep 11, 2023 · Price Performance Review of RGEN. On Friday, Repligen Corporation [NASDAQ:RGEN] saw its stock fall -4.03% to $161.42. On the same session, the stock had its day’s lowest price of $159.54, but rose to a high of $168.67. Over the last five days, the stock has lost -7.18%. Repligen Corporation shares have fallen nearly -4.66% since the year began. RGEN stock returns are also predicted based on historical data. According to our research, RGEN stock is a very good long-term investment. RGEN share price has been in a bull cycle for the past year.RGEN POWR Grades. Quality is the dimension where RGEN ranks best; there it ranks ahead of 59.48% of US stocks. RGEN's strongest trending metric is Growth; it's been moving down over the last 178 days. RGEN's current lowest rank is in the Growth metric (where it is better than 2.36% of US stocks). RGEN Stock SummaryPrice Performance Review of RGEN. On Friday, Repligen Corporation [NASDAQ:RGEN] saw its stock fall -4.03% to $161.42. On the same session, the stock had its day’s lowest price of $159.54, but rose to a high of $168.67. Over the last five days, the stock has lost -7.18%. Repligen Corporation shares have fallen nearly -4.66% since the year began.working papers njOct 12, 2021. The stock price of Repligen (NASDAQ: RGEN), a U.S.-based life sciences company involved in production of materials used in the manufacture of biological drugs, has seen a 12% drop ... Turning to the calls side of the option chain, the call contract at the $210.00 strike price has a current bid of $14.30. If an investor was to purchase shares of RGEN stock at the current price ...Repligen Corp. analyst estimates, including RGEN earnings per share estimates and analyst recommendations.On Friday, Repligen Corporation [NASDAQ:RGEN] saw its stock fall -3.14% to $157.80. On the same session, the stock had its day’s lowest price of $157.22, but rose to a high of $161.2916. Over the last five days, the stock has lost -8.37%. Repligen Corporation shares have fallen nearly -6.80% since the year began.Created with Sketch. when trading, helping you to optimize your price and have a successful order execution. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4 ...Shares of RGEN stock broke out of a cup base with a buy point at 212.65 on Thursday, according to MarketSmith.com. On the stock market today, RGEN stock gained 1.5% to close at 215.47.RGEN will take a dip in the coming day RGEN is going to dip if you feel you’re going to take a loss on this stock I would advise selling sooner rather then later. The chart that I’ve referenced is the Vortex Indicator and from my analysis the lines are going to cross negatively.Feb 4, 2021 · RGEN stock also has a nearly perfect EPS Rating of 98, indicative of its strong profitability. Keep tabs on IBD Digital for more stock ratings. Follow Allison Gatlin on Twitter at @IBD_AGatlin. Analyst Forecast. According to 9 analysts, the average rating for RGEN stock is "Strong Buy." The 12-month stock price forecast is $204.0, which is an increase of 26.38% from the latest price.The P/B ratio is used to compare a stock's market value with its book value, which is defined as total assets minus total liabilities. For comparison, RGEN has a P/B of 5.28. Story continueswww .repligen .com. Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs. 2014 The company is based in Waltham, Massachusetts, 2014 and incorporated in Delaware in 1981. [1] A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. [2] May 4, 2021 · RGEN stock analysts predicted earnings of $1.91 per share and $510 million in sales. Shares have a best-possible EPS Rating of 99, putting RGEN stock in the top 1% of all stocks in terms of ... Feb 20, 2023 · What Is Repligen Worth? The stock seems fairly valued at the moment according to my valuation model. It’s trading around 0.63% above my intrinsic value, which means if you buy Repligen today ... www jfs ohio gov ocs
What Is Repligen Worth? The stock seems fairly valued at the moment according to my valuation model. It’s trading around 0.63% above my intrinsic value, which means if you buy Repligen today ...Feb 20, 2023 · What Is Repligen Worth? The stock seems fairly valued at the moment according to my valuation model. It’s trading around 0.63% above my intrinsic value, which means if you buy Repligen today ... Investors. These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments. Sep 8, 2023 · Analyst Forecast. According to 9 analysts, the average rating for RGEN stock is "Strong Buy." The 12-month stock price forecast is $204.0, which is an increase of 26.38% from the latest price. Repligen Corp. analyst estimates, including RGEN earnings per share estimates and analyst recommendations. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, RGEN has a P/B of 5.36.Repligen Corp ( RGEN) receives a weak valuation ranking of 32 from InvestorsObserver data analysis. The proprietary ranking system focuses on the underlying health of a company through analysis of its stock price, earnings, and growth rate. RGEN has a better value than 32% of stocks based on these valuation analytics.Real time Repligen (RGEN) stock price quote, stock graph, news & analysis. Discover historical prices for RGEN stock on Yahoo Finance. View daily, weekly or monthly format back to when Repligen Corporation stock was issued.RGEN Nasdaq Stock Market • delayed by 15 minutes • CURRENCY IN USD • Healthcare Equipment & Supplies. REPLIGEN CORPORATION. REPLIGEN CORPORATION 167.54 ‎-2.74%. 167.54. at closeSep 8, 2023 · RGEN Stock Overview. Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. Sep 11, 2023 · Price Performance Review of RGEN. On Friday, Repligen Corporation [NASDAQ:RGEN] saw its stock fall -4.03% to $161.42. On the same session, the stock had its day’s lowest price of $159.54, but rose to a high of $168.67. Over the last five days, the stock has lost -7.18%. Repligen Corporation shares have fallen nearly -4.66% since the year began. mike freeman usa today
Turning to the calls side of the option chain, the call contract at the $210.00 strike price has a current bid of $14.30. If an investor was to purchase shares of RGEN stock at the current price ...RGEN Stock Overview. Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. About the companyOn Friday, Repligen Corporation [NASDAQ:RGEN] saw its stock jump 1.05% to $175.74. On the same session, the stock had its day’s lowest price of $175.105, but rose to a high of $179.27. Over the last five days, the stock has gained 6.66%. Repligen Corporation shares have risen nearly 3.80% since the year began.Analyzing RGEN Stock Performance. On Wednesday, Repligen Corporation [NASDAQ: RGEN] rose 0.69% to $158.97. The stock’s lowest price that day was $156.92, but it reached a high of $161.38 in the same session. During the last five days, there has been a drop of approximately -5.24%.Find the latest Repligen Corporation (RGEN) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.